FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044295583> ?p ?o ?g. }

• W2044295583 endingPage "307" @default.
• W2044295583 startingPage "300" @default.
• W2044295583 abstract "This study analyzed the antiatherogenic effects of newly developed apolipoprotein A-I (ApoA-I) mimetic peptide/phospholipid complexes (ETC-642) against the aortic plaque burden in vivo. We used human macrophage cells to analyze cholesterol efflux by ETC-642. Watanabe-heritable hyperlipidemic (WHHL) rabbits were divided into 3 groups: low- (15 mg/kg) and high-dose ETC-642 (50 mg/kg), and placebo. The test material was injected twice/week for 12 weeks. The aortic plaque burden was assessed by intravascular ultrasound (IVUS) at 0 and 12 weeks. Plasma lipid profiles were analyzed by capillary isotachophoresis every 4 weeks. ETC-642 had an effect on cholesterol efflux comparable to that of conventional rHDL. In WHHL rabbits, high-dose ETC-642 inhibited the progression of aortic atherosclerosis compared to placebo. There was no change in the percentage of plaque volume (%PV) in the high-dose group between before (30.9%) and after infusion (28.6%), whereas there was a significant increase in the control group from 27.8% to 37.9%. ETC-642 significantly reduced charge-modified low-density lipoprotein (LDL) by converting more negative-charged modified LDL to less negative-charged LDL, and reduced small dense (sd) LDL by converting it into large, buoyant (lb) LDL. Changes in the %PV were positively correlated with changes in negative-charged modified LDL (r = 0.61, p < 0.01) and sdLDL (r = 0.59, p < 0.01), and negatively correlated with changes in less negative-charged LDL (r = −0.43, p < 0.01) and lbLDL (r = −0.57, p < 0.01). In conclusion, the ETC-642-induced remodeling of sdLDL to large and lbLDL and the enhancement of cholesterol efflux may prevent progression of the aortic plaque burden. HDL-based therapy may be useful for preventing the progression of plaque volume." @default.
• W2044295583 created "2016-06-24" @default.
• W2044295583 creator A5010712555 @default.
• W2044295583 creator A5025276777 @default.
• W2044295583 creator A5032302089 @default.
• W2044295583 creator A5034214537 @default.
• W2044295583 creator A5062121150 @default.
• W2044295583 creator A5075639265 @default.
• W2044295583 creator A5088581847 @default.
• W2044295583 date "2011-10-01" @default.
• W2044295583 modified "2023-09-26" @default.
• W2044295583 title "Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits" @default.
• W2044295583 cites W1516536249 @default.
• W2044295583 cites W1683923016 @default.
• W2044295583 cites W1952062893 @default.
• W2044295583 cites W1968842522 @default.
• W2044295583 cites W1974099968 @default.
• W2044295583 cites W1991873228 @default.
• W2044295583 cites W1997567789 @default.
• W2044295583 cites W2014526613 @default.
• W2044295583 cites W2017479748 @default.
• W2044295583 cites W2020769052 @default.
• W2044295583 cites W2032809711 @default.
• W2044295583 cites W2049874253 @default.
• W2044295583 cites W2055865829 @default.
• W2044295583 cites W2081437358 @default.
• W2044295583 cites W2083454658 @default.
• W2044295583 cites W2095507444 @default.
• W2044295583 cites W2103322390 @default.
• W2044295583 cites W2107060427 @default.
• W2044295583 cites W2121639380 @default.
• W2044295583 cites W2122062568 @default.
• W2044295583 cites W2151074227 @default.
• W2044295583 cites W2164337795 @default.
• W2044295583 cites W2185919462 @default.
• W2044295583 cites W2339616051 @default.
• W2044295583 cites W2342524513 @default.
• W2044295583 doi "https://doi.org/10.1016/j.atherosclerosis.2011.05.029" @default.
• W2044295583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21696737" @default.
• W2044295583 hasPublicationYear "2011" @default.
• W2044295583 type Work @default.
• W2044295583 sameAs 2044295583 @default.
• W2044295583 citedByCount "43" @default.
• W2044295583 countsByYear W20442955832012 @default.
• W2044295583 countsByYear W20442955832013 @default.
• W2044295583 countsByYear W20442955832014 @default.
• W2044295583 countsByYear W20442955832015 @default.
• W2044295583 countsByYear W20442955832016 @default.
• W2044295583 countsByYear W20442955832017 @default.
• W2044295583 countsByYear W20442955832018 @default.
• W2044295583 countsByYear W20442955832019 @default.
• W2044295583 countsByYear W20442955832020 @default.
• W2044295583 countsByYear W20442955832021 @default.
• W2044295583 countsByYear W20442955832022 @default.
• W2044295583 countsByYear W20442955832023 @default.
• W2044295583 crossrefType "journal-article" @default.
• W2044295583 hasAuthorship W2044295583A5010712555 @default.
• W2044295583 hasAuthorship W2044295583A5025276777 @default.
• W2044295583 hasAuthorship W2044295583A5032302089 @default.
• W2044295583 hasAuthorship W2044295583A5034214537 @default.
• W2044295583 hasAuthorship W2044295583A5062121150 @default.
• W2044295583 hasAuthorship W2044295583A5075639265 @default.
• W2044295583 hasAuthorship W2044295583A5088581847 @default.
• W2044295583 hasConcept C126322002 @default.
• W2044295583 hasConcept C134018914 @default.
• W2044295583 hasConcept C142724271 @default.
• W2044295583 hasConcept C150903083 @default.
• W2044295583 hasConcept C185592680 @default.
• W2044295583 hasConcept C204787440 @default.
• W2044295583 hasConcept C207001950 @default.
• W2044295583 hasConcept C27081682 @default.
• W2044295583 hasConcept C2778163477 @default.
• W2044295583 hasConcept C2778918659 @default.
• W2044295583 hasConcept C2780072125 @default.
• W2044295583 hasConcept C41625074 @default.
• W2044295583 hasConcept C55493867 @default.
• W2044295583 hasConcept C62746215 @default.
• W2044295583 hasConcept C71924100 @default.
• W2044295583 hasConcept C86803240 @default.
• W2044295583 hasConceptScore W2044295583C126322002 @default.
• W2044295583 hasConceptScore W2044295583C134018914 @default.
• W2044295583 hasConceptScore W2044295583C142724271 @default.
• W2044295583 hasConceptScore W2044295583C150903083 @default.
• W2044295583 hasConceptScore W2044295583C185592680 @default.
• W2044295583 hasConceptScore W2044295583C204787440 @default.
• W2044295583 hasConceptScore W2044295583C207001950 @default.
• W2044295583 hasConceptScore W2044295583C27081682 @default.
• W2044295583 hasConceptScore W2044295583C2778163477 @default.
• W2044295583 hasConceptScore W2044295583C2778918659 @default.
• W2044295583 hasConceptScore W2044295583C2780072125 @default.
• W2044295583 hasConceptScore W2044295583C41625074 @default.
• W2044295583 hasConceptScore W2044295583C55493867 @default.
• W2044295583 hasConceptScore W2044295583C62746215 @default.
• W2044295583 hasConceptScore W2044295583C71924100 @default.
• W2044295583 hasConceptScore W2044295583C86803240 @default.
• W2044295583 hasFunder F4320307765 @default.
• W2044295583 hasFunder F4320320912 @default.
• W2044295583 hasIssue "2" @default.

• next